Clinical Guidelines for Antidepressant Dosage Must Reflect the Evidence
New analysis shows the lower range of the licensed dose of the most commonly used second-generation antidepressants achieves the optimal balance between efficacy, tolerability and acceptability in the acute treatment of adults with major depression.
Read moreEpilepsy drugs linked to increased risk of suicidal behaviour, particularly in young people
Treatment with gabapentinoids - a group of drugs used for epilepsy, nerve pain and anxiety disorders - is associated with an increased risk of suicidal behaviour, unintentional overdose, injuries, and road traffic incidents.
Read moreExperts call for new kind of registry for deployment of psychedelics as medicines
The US Food and Drug Administration (FDA) has recently licensed a form of ketamine – esketamine – as a treatment for depression which is resistant to other treatments. It is administered as a nasal spray in a clinic, initially twice a week, then weekly or fortnightly. Regular doses of the drug are necessary to prevent relapse.
Read moreSelf-harm in Children and Adolescents: A Major Health and Social Problem of our Time
In the Jack Tizard Memorial Lecture during the Association for Child and Mental Health National Conference at the Royal College of Physicians, Professor Keith Hawton, highlighted the very worrying recent increases in rates of suicide in England in older adolescents and the big rise in self-harm in young teenage females.
Read moreOxford Health uses Oxehealth technology to transform patient observations at night
Mental Health Trust uses clinically validated digital technology to enable nurses to carry out vital checks on patients with mental health conditions, without disturbing their sleep.
Read more£9 million investment for health and social care research
The NIHR Applied Research Collaboration for Oxford and Thames Valley will launch in October 2019. It is one of 15 ARC's across England, each will work with local and national partners to address some of the nation’s most pressing challenges faced by the health and care system over the next 5 years, including dementia, obesity and mental health.
Read more
What do we research?
Work with us
Study with us
Latest News
Talks, discussions, events
-
Old Age Psychiatry CPD meeting
Professor Sarah Pendlebury & Dr Hugh Series
Wednesday, 09 October 2019, 2pm to 5pm
Departmental facts and figures
